MedPath

Cholesterol-lowering Effects of Plant Stanol Ester

Not Applicable
Completed
Conditions
Dyslipidemias
Hypercholesterolemia
Hyperlipidemias
Registration Number
NCT02316808
Lead Sponsor
Raisio Group
Brief Summary

Efficacy of plant stanols as esters on LDL-cholesterol reduction is well documented. LDL-cholesterol lowering efficacy of the ingredient administered in a smoothie is less well known.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
91
Inclusion Criteria
  • total cholesterol concentration ≥ 200 mg/dL and < 300 mg/dL, and or LDL-C concentration ≥ 130 mg/dL and < 180 mg/dL
  • were willing to consume control or plant stanol ester smoothie drinks two bottles per day immediately after a meal for four weeks,
  • reachable by phone
  • willing to declare written informed consent
  • agreed in accordance with data protective stipulations and readiness to participate in the trial and to adhere to the study conditions.
Exclusion Criteria
  • Pregnant women
  • obese
  • diabetic subjects or subjects with random plasma glucose concentration > 200 mg/dL
  • hyperthyroidism, a history of metabolic, endocrine and kidney disorders
  • acute or chronic severe diseases possibly interfering with the evaluation of the outcome of the clinical trial (such as AIDS, tumor diseases, malignant hypertension, cardiac insufficiency according to NYHA III-IV)
  • taking lipid-lowering medication or other medications likely to affect lipid metabolism

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change (proportional) in LDL-C from baseline up to 4-weeks after plant stanol ester smoothie drink consumption.4 weeks
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.